NovaQuest Capital Management, L.L.C. is a fund manager in Raleigh with $1.79 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
273425707
SEC advisor number
801-73992
FINRA CRD number
160359
AUM ?
$1.79 bn
(as of 8 Jun 23)
Accounts
39
(as of 8 Jun 23)
Employees
29
(28 investment advisory or research)
Address
NovaQuest Capital Management, L.L.C.
4208 SIX FORKS ROAD
SUITE 920
RALEIGH
NC 27609
4208 SIX FORKS ROAD
SUITE 920
RALEIGH
NC 27609
Office hours
Monday - Friday, 9:00 AM - 5:00 PM
Phone
919-459-8616
Brochures
Ownership
Owner | Title | From | %Ownership |
---|---|---|---|
Wooten, Ronald, John | Member, Senior Founding Partner, Management Committee Member | 11/2010 | 10-25% |
Bradley, John, Layton | Member, Founding Partner, Management Committee Member | 11/2010 | 5-10% |
Tunnicliffe, Jonathan, Edward | Member, Managing Partner, Chief Investment Officer | 11/2010 | 5-10% |
Pharmabio Development Inc. | Member | 11/2010 | 50-75% |
MBK Pharmapartnering, Inc. | Member | 11/2010 | 10-25% |
Hester, Robert, Wayne | Member, Chief Financial Officer, Executive Vice President | 11/2010 | < 5% |
Gillings, Dennis, Barry | Shareholder | 01/2022 | > 75% |
Mitsui & Co., LTD. | Shareholder | 11/2010 | > 75% |
Brown, Ernest, Gerald | Management Committee Member | 11/2010 | < 5% |
Mills, Bryan, Edwards | Member, Chief Administrative Officer | 01/2020 | < 5% |
Comer, Jacob, Ernest | Member, General Counsel & Chief Compliance Officer | 05/2020 | < 5% |
Tanaka, Hidekazu | Management Committee Member | 04/2021 | < 5% |
Jordan, Patrick, Brooks | Member, Managing Partner, Chief Operating Officer | 04/2021 | < 5% |
GF Management Holdings Inc. | Shareholder | 01/2022 | > 75% |
Gillings, Mireille | Shareholder | 01/2022 | 25-50% |
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Novaquest Capital Management, L.L.C. | $1.79 bn | |
Novaquest Animal Health Opportunities Fund (Delaware), L.P. | $80.63 mm | Private Equity Fund |
Novaquest Animal Health Opportunities Fund Aggregator, L.P. | $89.82 mm | Private Equity Fund |
Novaquest Animal Health Opportunities Fund, L.P. | $5.95 mm | Private Equity Fund |
Novaquest Co-investment - Risp, L.P. | $26.88 mm | Private Equity Fund |
Novaquest Co-investment - Tak, L.P. | $3.00 mm | Private Equity Fund |
Novaquest Co-investment Fund I (Parent), L.P. | $565.00 k | Private Equity Fund |
Novaquest Co-investment Fund III, L.P. | $32.50 mm | Private Equity Fund |
Novaquest Co-investment Fund IX, L.P. | $60.17 mm | Private Equity Fund |
Novaquest Co-investment Fund VI, L.P. | $25.92 mm | Private Equity Fund |
Novaquest Co-investment Fund VII, L.P. | $39.39 mm | Private Equity Fund |
Novaquest Co-investment Fund VIII, L.P. | $241.63 mm | Private Equity Fund |
Novaquest Co-investment Fund XI, L.P. | $25.47 mm | Private Equity Fund |
Novaquest Co-investment Fund XIII, L.P. | $24.99 mm | Private Equity Fund |
Novaquest Co-investment Fund XV, L.P. | $38.71 mm | Private Equity Fund |
Novaquest Co-investment Fund XVI, L.P. | $74.23 mm | Private Equity Fund |
Novaquest Co-investment Fund XVII, L.P. | $50.18 mm | Private Equity Fund |
Novaquest Co-investment Fund XVIII, L.P. | $36.62 mm | Private Equity Fund |
Novaquest Fund III Aiv I, L.P. | $357.00 k | Private Equity Fund |
Novaquest Pharma Opportunities Fund III Aggregator, L.P. | $36.35 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund III, L.P. | $57.64 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Co-invest-a), L.P. | $8.67 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Co-invest-a), L.P. | $27.87 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Co-invest), L.P. | $73.69 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV (Parallel), L.P. | $31.07 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV Aggregator, L.P. | $152.22 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund IV, L.P. | $230.24 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund V (Delaware), L.P. | $396.66 mm | Private Equity Fund |
Novaquest Pharma Opportunities Fund V (Delaware) Feeder, L.P. | ||
Novaquest Pharma Opportunities Fund V, L.P. | $679.44 mm | Private Equity Fund |
NQ Ah Project Arlington II, L.P. | $13.40 mm | Private Equity Fund |
NQ Cove Aggregator, L.P. | $18.80 mm | Private Equity Fund |
NQ Project Bridgeton, L.P. | $73.35 mm | Private Equity Fund |
NQ Project Glasgow, LTD. | $75.58 mm | Private Equity Fund |
NQ Project Pharaoh, L.P. | $129.41 mm | Private Equity Fund |
NQ Project Phoebus, L.P. | $51.06 mm | Private Equity Fund |
NQ Project Sampson, L.P. | $35.52 mm | Private Equity Fund |
NQP Aiv I, L.P. | $105.40 mm | Private Equity Fund |
NQP SPV I, L.P. | $184.57 mm | Private Equity Fund |
NQP SPV II, L.P. | $86.57 mm | Private Equity Fund |
Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
13 Nov 20
13F-HR
Quarterly holdings report by institutional manager
24 Jul 20
13F-HR
Quarterly holdings report by institutional manager
24 Apr 20
13F-HR
Quarterly holdings report by institutional manager
24 Jan 20
13F-HR
Quarterly holdings report by institutional manager
25 Oct 19
13F-HR
Quarterly holdings report by institutional manager
29 Jul 19
13F-HR
Quarterly holdings report by institutional manager
8 May 19
13F-HR
Quarterly holdings report by institutional manager
12 Feb 19
13F-HR
Quarterly holdings report by institutional manager
7 Nov 18
13F-HR
Quarterly holdings report by institutional manager
1 Aug 18